Delving into the Latest Updates on Shanghai Haixin Bio-tech Co., Ltd. with Synapse

Overview

Tags

Digestive System Disorders

Neoplasms

Cell therapy

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

No Data

Disease Domain	Count

Neoplasms	1

Top 5 Drug Type	Count

Cell therapy	1

This trial is to compare the efficacy and safety of modified FOLFOX6 [mFOLFOX6, a specific chemotherapy regimen of Oxaliplatin ,5-Fluorouracil and Leucovorin] chemotherapy plus Antigen Pulsed Dendritic Cells (APDC，a kind of autologous tumor lysates pulsed human dendritic cells vaccine) with modified chemotherapy alone in patients with metastatic colorectal cancer.

Start Date01 Jul 2015

Sponsor / Collaborator

The Second Military Medical University

[+14]

100 Clinical Results associated with Shanghai Haixin Bio-tech Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Shanghai Haixin Bio-tech Co., Ltd.

Login to view more data

100 Deals associated with Shanghai Haixin Bio-tech Co., Ltd.

Login to view more data

100 Translational Medicine associated with Shanghai Haixin Bio-tech Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 07 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 3 Clinical

1

Other

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

Antigen Pulsed Dendritic Cells(Shanghai Hisun Biotechnology)	Metastatic Colorectal Carcinoma More	Phase 3
Antigen Pulsed Dendritic Cells(Shanghai Haixin Biotechnology)	Colorectal Cancer More	Pending